Philips Launches a New Era in Cardiac Diagnostics
Philips, a leader in health technology, has unveiled an exciting new platform designed to transform cardiac care: the Philips ECG AI Marketplace. This innovative marketplace is set to empower cardiac care teams with access to a variety of AI-powered diagnostic tools and resources, all conveniently located in one central hub.
AI-Driven Insights for Better Patient Care
At the forefront of this initiative is Anumana, an AI-centric health technology firm. Their FDA-cleared ECG-AI™ LEF (Low Ejection Fraction) algorithm is the first offering on Philips' new platform. This collaboration marks a significant move towards integrating advanced technologies into routine cardiac assessments.
Enhancing Clinical Workflow
With healthcare organizations increasingly embracing AI-driven solutions, the Philips ECG AI Marketplace promises to simplify this adoption for U.S. hospitals and health systems. By enabling seamless integration of validated algorithms into existing workflows, clinicians can spend less time on manual analysis and more on direct patient engagement. This not only accelerates the diagnostic process but also enhances operational efficiency.
Supporting Cardiologists with Valuable Tools
Stefano Folli, Business Leader at Philips, emphasized the importance of the Marketplace in fostering a more connected health care innovation landscape. "This platform addresses the need for streamlined access to AI tools that ultimately improve the healthcare experience for both clinicians and patients,” he stated. The benefits of these resources are amplified by the accessibility at the point of care, allowing for quicker and more informed clinical decisions.
Putting AI to Work in Cardiac Diagnostics
Anumana's LEF algorithm utilizes standard 12-lead resting ECG tests to detect early indicators of heart failure, such as reduced ejection fraction. By incorporating this AI technology into their processes, healthcare providers are equipped with essential insights that support timely interventions.
A Commitment to Patient Outcomes
As Simos Kedikoglou, the President and COO of Anumana, highlighted, their partnership with Philips enhances the reach of their innovations. With rigorous evaluation based on extensive studies involving over 150,000 patients, their algorithms are built upon a foundation of validated clinical research. This dedication ensures that clinicians can rely on these tools to deliver timely care and improve outcomes for at-risk patients.
A Broader Vision for Third-Party Collaborations
Philips' collaboration with Anumana represents just the beginning of their broader strategy to expand their ECG ecosystem. By opening up to additional third-party innovations, Philips is enhancing the availability of AI diagnostics, which can have a profound impact on early cardiovascular disease detection and treatment. This initiative embodies a commitment to better healthcare through technological advancement.
Contact Information
For more details, reach out to: Allison Johnson, Director, Monitoring Communications, Philips.
Tel: +1 617-631-7305
Email: allison.johnson@philips.com
About Royal Philips
Royal Philips (NYSE: PHG) is committed to improving global health through innovative technology. With a focus on patient-centric approaches, Philips operates across a range of health solutions, including diagnostic imaging and monitoring. Headquartered in the Netherlands, the company continues to expand its global footprint, delivering transformative healthcare innovations that empower both patients and healthcare providers.
Frequently Asked Questions
What is the Philips ECG AI Marketplace?
The Philips ECG AI Marketplace is a central platform for healthcare teams, providing access to various AI-powered diagnostic tools to enhance cardiac care.
Which company is the first to offer an algorithm on this platform?
Anumana is the first company to provide its FDA-cleared LEF algorithm through the Philips ECG AI Marketplace.
How does the LEF algorithm benefit healthcare providers?
The LEF algorithm helps detect early signs of heart failure, enabling timely and informed clinical decisions based on ECG results.
What are the advantages of using the Philips ECG AI Marketplace?
This platform simplifies the integration of AI tools into existing workflows, enhances diagnostic efficiency, and reduces operational costs for healthcare providers.
How does Philips plan to expand its ECG ecosystem?
Philips aims to collaborate with multiple third-party vendors, integrating diverse solutions to advance AI diagnostics in cardiac care.
